Laxminarayan Bhat
President and CEO, Director at Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Laxminarayan Bhat has filed 4 insider reports with the SEC since April 2023, as president and CEO and director at Reviva Pharmaceuticals Holdings, Inc. (RVPH). The latest filing, on March 20, 2026, reports grant or award at Reviva Pharmaceuticals Holdings, Inc. (RVPH).
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Laxminarayan Bhat is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEO, Director | $0.3521 | Mar 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 18, 2026RVPHSEC Form 4 filed by Bhat LaxminarayanForm 4Grant or award
- Feb 13, 2025RVPHSEC Form 4 filed by President and CEO Bhat LaxminarayanForm 4Grant or award
- Sep 15, 2024RVPHSEC Form 4 filed by President and CEO Bhat LaxminarayanForm 4Grant or award
- Apr 25, 2023RVPHSEC Form 4 filed by Bhat LaxminarayanForm 4Grant or award
Compare Laxminarayan Bhat with
- Laxminarayan Bhat vs Narayan Prabhu1 shared
- Laxminarayan Bhat vs Leslie D. Funtleyder1 shared
- Laxminarayan Bhat vs Richard A Margolin1 shared
- Laxminarayan Bhat vs Purav Patel1 shared
- Laxminarayan Bhat vs Parag Saxena1 shared
Other insiders at the same companies
Questions about Laxminarayan Bhat
- What is Laxminarayan Bhat's role at Reviva Pharmaceuticals Holdings, Inc.?
- Laxminarayan Bhat reports to the SEC as president and CEO and director at Reviva Pharmaceuticals Holdings, Inc. (RVPH), according to the latest filing on March 20, 2026.
- Has Laxminarayan Bhat bought or sold stock recently?
- No open-market purchases or sales by Laxminarayan Bhat are on file. The filings report grant or award.
- How do I get alerts when Laxminarayan Bhat files?
- Follow Laxminarayan Bhat on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Laxminarayan Bhat (SEC CIK 0001818245). Totals count each trade once, skipping amendments whose original is on file, from Apr 27, 2023 on. View on SEC EDGAR